Raimar Löbenberg
Director, DDIC
Dr. Raimar Löbenberg is an expert in area of pharmaceutics, drug development and delivery. He is a member of the United States Pharmacopoeia (USP) expert committee for Dietary Supplements and Herbal Medicines and chair of the subcommittee for performance testing of dietary supplements, member of the American Association of Pharmaceutical Scientists (AAPS) Steering Committee for Drug Release and Dissolution Testing and vice chair of Speciality Committee for Pharmaceutical Quality of Traditional Medicines of the World Foundation of Traditional Chinese Medicines, and a past president of the Canadian Society for Pharmaceutical Sciences.
Neal Davies
Dean, UAlberta Pharmacy & Pharm Sci
As Dean of the University of Alberta’s Faculty of Pharmacy and Pharmaceutical Sciences, Dr. Neal Davies is a passionate proponent of the value to be found at the intersection of science and industry. Dr. Davies has over 25 years of experience as a researcher working with industry funders and the National Institutes of Health. While leading the faculty Dr. Davies maintains an active and highly collaborative research program focused on pharmacokinetics and drug delivery and serves on the boards of several pharmaceutical science journals and the Institute of Health Economics.
John Mackey
Director, CCI Clinical Trials Unit
Dr. John Mackey is a medical oncologist with 20 years of clinical experience treating breast cancer patients. He serves as Director of the Cross Cancer Institute Clinical Trials Unit. Dr. Mackey’s translational research focus is the development of predictive biomarkers, and novel targets and pathways for improved systemic cancer therapy.
